4Basebio PLC
LSE:4BB
Cash Flow Statement
Cash Flow Statement
4Basebio PLC
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(3)
|
(4)
|
(5)
|
(6)
|
(8)
|
(10)
|
(12)
|
(14)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
| Cash Taxes Paid |
0
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
0
|
1
|
1
|
1
|
0
|
1
|
(0)
|
|
| Cash from Operating Activities |
(3)
N/A
|
(4)
-29%
|
(5)
-33%
|
(5)
-11%
|
(6)
-18%
|
(8)
-35%
|
(11)
-29%
|
(14)
-28%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(2)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(2)
N/A
|
(3)
-66%
|
(2)
+23%
|
(1)
+33%
|
(1)
-14%
|
(1)
+3%
|
(2)
-8%
|
(2)
+3%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
1
|
39
|
38
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
(0)
|
(0)
|
1
|
5
|
7
|
8
|
5
|
0
|
|
| Cash from Financing Activities |
(0)
N/A
|
(0)
+22%
|
1
N/A
|
5
+277%
|
6
+37%
|
9
+37%
|
44
+398%
|
39
-12%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
(1)
|
(1)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
|
| Net Change in Cash |
(5)
N/A
|
(7)
-28%
|
(5)
+25%
|
(2)
+61%
|
(1)
+37%
|
(1)
+34%
|
32
N/A
|
23
-26%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(4)
N/A
|
(6)
-42%
|
(7)
-10%
|
(7)
+2%
|
(8)
-17%
|
(10)
-28%
|
(12)
-26%
|
(15)
-24%
|
|